Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 242

1.

Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.

Rego EM, Ruggero D, Tribioli C, Cattoretti G, Kogan S, Redner RL, Pandolfi PP.

Oncogene. 2006 Mar 23;25(13):1974-9.

PMID:
16331271
2.

Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha.

Cheng GX, Zhu XH, Men XQ, Wang L, Huang QH, Jin XL, Xiong SM, Zhu J, Guo WM, Chen JQ, Xu SF, So E, Chan LC, Waxman S, Zelent A, Chen GQ, Dong S, Liu JX, Chen SJ.

Proc Natl Acad Sci U S A. 1999 May 25;96(11):6318-23.

3.

The molecular biology of acute promyelocytic leukemia.

Slack JL, Gallagher RE.

Cancer Treat Res. 1999;99:75-124. Review.

PMID:
9891864
4.

Acute promyelocytic leukemia: from clinic to molecular biology.

Chen SJ, Wang ZY, Chen Z.

Stem Cells. 1995 Jan;13(1):22-31. Review.

PMID:
7719245
5.

Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.

Grimwade D, Solomon E.

Curr Top Microbiol Immunol. 1997;220:81-112. Review.

PMID:
9103677
6.

Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.

He LZ, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A, Pandolfi PP.

Nat Genet. 1998 Feb;18(2):126-35.

PMID:
9462740
7.

PML, PLZF and NPM genes in the molecular pathogenesis of acute promyelocytic leukemia.

Pandolfi PP.

Haematologica. 1996 Sep-Oct;81(5):472-82. Review.

8.

Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signalling.

Ruthardt M, Testa U, Nervi C, Ferrucci PF, Grignani F, Puccetti E, Grignani F, Peschle C, Pelicci PG.

Mol Cell Biol. 1997 Aug;17(8):4859-69.

9.

Mechanisms of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells.

Zhang JW, Wang JY, Chen SJ, Chen Z.

J Biosci. 2000 Sep;25(3):275-84. Review.

PMID:
11022230
10.
11.
13.

[Basic and clinical studies of the gene product-targeting therapy based on leukemogenesis--editorial].

Chen SJ, Chen LJ, Zhou GB.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Feb;13(1):1-8. Chinese.

PMID:
15748426
14.

Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.

Ahn MJ, Nason-Burchenal K, Moasser MM, Dmitrovsky E.

Oncogene. 1995 Jun 15;10(12):2307-14.

PMID:
7784078
15.

Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia.

Chen Z, Tong JH, Dong S, Zhu J, Wang ZY, Chen SJ.

Genes Chromosomes Cancer. 1996 Mar;15(3):147-56. Review.

PMID:
8721678
16.

The acute promyelocytic leukaemia specific PML and PLZF proteins localize to adjacent and functionally distinct nuclear bodies.

Ruthardt M, Orleth A, Tomassoni L, Puccetti E, Riganelli D, Alcalay M, Mannucci R, Nicoletti I, Grignani F, Fagioli M, Pelicci PG.

Oncogene. 1998 Apr 16;16(15):1945-53.

17.

Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia.

Hummel JL, Wells RA, Dubé ID, Licht JD, Kamel-Reid S.

Oncogene. 1999 Jan 21;18(3):633-41.

18.

The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion.

Redner RL, Rush EA, Faas S, Rudert WA, Corey SJ.

Blood. 1996 Feb 1;87(3):882-6.

19.

The molecular genetics of acute promyelocytic leukemia.

Grignani F, Fagioli M, Ferrucci PF, Alcalay M, Pelicci PG.

Blood Rev. 1993 Jun;7(2):87-93. Review.

PMID:
8396481
20.

PML, a growth suppressor disrupted in acute promyelocytic leukemia.

Mu ZM, Chin KV, Liu JH, Lozano G, Chang KS.

Mol Cell Biol. 1994 Oct;14(10):6858-67.

Supplemental Content

Support Center